Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Proschmann, Undine"'
Autor:
Shalchi-Amirkhiz, Puya, Bensch, Tristan, Proschmann, Undine, Stock, Ann-Kathrin, Ziemssen, Tjalf, Akgün, Katja
Objective: This pilot study explores the influence of acute alcohol exposure on cell mechanical properties of steady-state and activated leukocytes conducted with real-time deformability cytometry. Methods: Nineteen healthy male volunteers were enrol
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A92815
https://tud.qucosa.de/api/qucosa%3A92815/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A92815/attachment/ATT-0/
Autor:
Proschmann, Undine, Shalchi-Amirkhiz, Puya, Andres, Pauline, Haase, Rocco, Inojosa, Hernán, Ziemssen, Tjalf, Akgün, Katja
Objective: The study aimed to investigate the effect of exercise on immune cell count and cell mechanical properties in people with multiple sclerosis (pwMS) on different disease-modifying treatments (DMT) vs. healthy controls (HCs). Methods: A cohor
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A92808
https://tud.qucosa.de/api/qucosa%3A92808/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A92808/attachment/ATT-0/
Autor:
Proschmann, Undine, Mueller-Enz, Magdalena, Woopen, Christina, Katoul Al Rahbani, Georges, Haase, Rocco, Dillenseger, Anja, Dunsche, Marie, Atta, Yassin, Ziemssen, Tjalf, Akgün, Katja
Background: Sphingosine 1-phosphat receptor modulators (S1PRMs) have been linked to attenuated immune response to SARS-CoV-2 vaccines. Objective: To characterize differences in the immune response to SARS-CoV-2 vaccines in patients on selective versu
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A92805
https://tud.qucosa.de/api/qucosa%3A92805/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A92805/attachment/ATT-0/
Multiple sclerosis (MS) is the most common chronic autoimmune neurological disease. Its therapeutic management has drastically evolved in the recent years with the development of specific disease-modifying therapies (DMTs). Together with the establis
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A91076
https://tud.qucosa.de/api/qucosa%3A91076/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A91076/attachment/ATT-0/
Background: Managing medication during pregnancy and lactation in multiple sclerosis (MS) patients needs to balance potential risks to the newborn with the substantial risks of ongoing disease activity. Objective: To evaluate the potential transfer o
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A35529
https://tud.qucosa.de/api/qucosa%3A35529/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A35529/attachment/ATT-0/
Autor:
Rodriguez-Leal, Francisco Alejandro, Haase, Rocco, Thomas, Katja, Eisele, Judith Christina, Proschmann, Undine, Schultheiss, Thorsten, Kern, Reimar, Ziemssen, Tjalf
Objective: The primary objective of this real-world study was to describe the response to fampridine and changes of gait parameters in multiple sclerosis (MS) patients’ walking disability (Expanded Disability Status Scale (EDSS): 4–7) after treat
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A35526
https://tud.qucosa.de/api/qucosa%3A35526/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A35526/attachment/ATT-0/
Van Kempen et al. described high natalizumab concentrations in their natalizumab-treated multiple sclerosis (MS) patients at time of re-dosing. Based on the literature research the authors consider a natalizumab concentration above 2 μg/mL to be suf
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A35528
https://tud.qucosa.de/api/qucosa%3A35528/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A35528/attachment/ATT-0/
Autor:
Thomas, Katja, Sehr, Tony, Proschmann, Undine, Rodriguez-Leal, Francisco Alejandro, Haase, Rocco, Ziemssen, Tjalf
Publikováno v:
Journal of Neuroinflammation 2017, 14(1). ISSN 1742-2094. DOI: 10.1186/s12974-017-0817-6. Artikelnr. 41
Background Growing evidence emphasizes the relevance of sphingolipids for metabolism and immunity of antigen-presenting cells (APC). APCs are key players in balancing tolerogenic and encephalitogenic responses in immunology. In contrast to the well-k
Externí odkaz:
http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-227035
http://www.qucosa.de/fileadmin/data/qucosa/documents/22703/s12974-017-0817-6.pdf
http://www.qucosa.de/fileadmin/data/qucosa/documents/22703/s12974-017-0817-6.pdf
Autor:
Sehr, Tony, Proschmann, Undine, Thomas, Katja, Marggraf, Michaela, Straube, Elmar, Reichmann, Heinz, Chan, Andrew, Ziemssen, Tjalf
Publikováno v:
Journal of Neuroinflammation, 2016, 13(1). ISSN 1742-2094. DOI: 10.1186/s12974-016-0635-2. Artikelnr. 164
Background The monoclonal antibody natalizumab (NAT) inhibits the migration of lymphocytes throughout the blood–brain barrier by blocking very late antigen (VLA)-4 interactions, thereby reducing inflammatory central nervous system (CNS) activity in
Externí odkaz:
http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-213630
http://www.qucosa.de/fileadmin/data/qucosa/documents/21363/ziemssen.pdf
http://www.qucosa.de/fileadmin/data/qucosa/documents/21363/ziemssen.pdf
Autor:
Voigt, Isabel, Fischer, Stefanie, Proschmann, Undine, Konofalska, Urszula, Richter, Peggy, Schlieter, Hannes, Berger, Thomas, Meuth, Sven G., Hartung, Hans-Peter, Akgün, Katja, Ziemssen, Tjalf
Publikováno v:
In The Lancet Regional Health - Europe May 2024 40
